Mifepristone is prescribed to patients who need critical, time-sensitive reproductive care, including for abortions and the treatment of miscarriages
February 10, 2023 – OAKLAND — California Attorney General Rob Bonta today joined a coalition of 22 attorneys general in a legal fight to protect nationwide access to mifepristone, which is widely used for medication abortion. The attorneys general filed an amicus brief opposing a lawsuit that challenges the Food and Drug Administration’s (FDA) approval of mifepristone, despite the fact that mifepristone has been approved for more than 20 years. Mifepristone is prescribed to patients who need critical, time-sensitive reproductive care, including for abortions and the treatment of miscarriages. The plaintiffs in the lawsuit, Alliance for Hippocratic Medicine et al. v. FDA, are currently seeking a preliminary injunction that would force the FDA to rescind its approval of mifepristone.
“Make no mistake: This lawsuit is an attack on the reproductive freedoms of millions,” said Attorney General Bonta. “When people’s access to critical health care is cut off, it’s our most vulnerable communities who pay the biggest price. Mifepristone is a lifeline to people across the nation, especially those who must travel long distances to access reproductive healthcare. My office will fight to protect and defend all Californians’ access to safe and legal abortions wherever and whenever it is threatened.”
On November 18, a group of plaintiffs led by the Alliance for Hippocratic Medicine filed a complaint in the U.S. District Court for the Northern District of Texas against the FDA and the U.S. Department of Health and Human Services (HHS). The lawsuit argued that the FDA overstepped its authority when it approved mifepristone for use as medication abortion in 2000, because it does not provide a ‘meaningful therapeutic benefit’ over other available treatments such as surgical abortion procedures.